pd 173074 has been researched along with Syndrome in 1 studies
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudernova, I | 1 |
| Vesela, I | 1 |
| Balek, L | 1 |
| Buchtova, M | 1 |
| Dosedelova, H | 1 |
| Kunova, M | 1 |
| Pivnicka, J | 1 |
| Jelinkova, I | 1 |
| Roubalova, L | 1 |
| Kozubik, A | 1 |
| Krejci, P | 1 |
1 other study available for pd 173074 and Syndrome
| Article | Year |
|---|---|
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocyt | 2016 |